{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:14:09Z","timestamp":1793236449337,"version":"4.5.0"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011844","name":"Science and Technology Department, Heilongjiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011844","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ferroptosis, a novel mode of apoptosis has recently been shown to be associated with fibrosis, tumor, cardiovascular, and other diseases. In this study, using bioinformatic analysis, we identified ferroptosis genes associated with Crohn\u2019s disease (CD) and performed biological function analysis, identified potential drug targets, and provided new directions for the future treatment of CD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Differential expression analysis was performed using the GSE186582 dataset from the Gene Expression Omnibus (GEO) database. Ferroptosis-associated genes were downloaded from the FerrDB database, and overlapping genes associated with CD and ferroptosis were extracted. Then, we performed functional enrichment analysis, constructed a protein-protein interaction network (PPI), identified the correlation between hub genes and immune infiltration, performed external validation using a second and third dataset (GSE102133, GSE95095), and identified potential therapeutic agents. Finally, we validated the protein expression levels of the identified hub genes by immunohistochemical staining in the colon tissues from CD and healthy participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 28 ferroptosis-associated genes associated with CD were identified in our analysis, which included 22 up-regulated and 6 down-regulated genes. Gene Ontology (GO) analysis showed that these genes are essential for the apical plasma membrane and amide transport, and Metascape analysis showed that these genes mainly act on IL-4 and IL-13 signaling pathways. Five hub genes, PTGS2, IL6, IL1B, NOS2, and IDO1, were identified by a protein interaction network, and external validation of these hub genes showed statistically significant differences in expression between the CD patients and normal participants (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.05), and all AUC values were greater than 0.8. Further, we predicted the top 10 drugs used to treat CD. Immune infiltration results suggest that Hub gene is related to T cells, macrophages, dendritic cells, and other immune cells. Finally, the results of immunohistochemical experiments showed that the protein expression of the hub gene was higher in CD colon tissue than in normal subjects (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Bioinformatics analysis showed that ferroptosis is closely related to the development of CD, and the prediction of potential drugs provides new targets for the treatment of CD. Moreover, five hub genes identified are potentially new and effective markers for the diagnosis of CD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2022.1058076","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T23:58:21Z","timestamp":1673567901000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Analysis of ferroptosis-associated genes in Crohn\u2019s disease based on bioinformatics"],"prefix":"10.3389","volume":"9","author":[{"given":"Xingyu","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/ibd\/izz155","article-title":"Cancer risk in inflammatory bowel disease: a 6-year prospective multicenter nested case-control IG-IBD Study.","volume":"26","author":"Biancone","year":"2020","journal-title":"Inflamm Bowel Dis."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/cells8060548","article-title":"Capturing the biologic onset of inflammatory bowel diseases: impact on translational and clinical science.","volume":"8","author":"Sorrentino","year":"2019","journal-title":"Cells."},{"key":"B3","first-page":"661","article-title":"Crohn\u2019s disease: diagnosis and management.","volume":"98","author":"Veauthier","year":"2018","journal-title":"Am Fam Physician."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1053\/j.gastro.2010.06.070","article-title":"Risk factors associated with progression to intestinal complications of Crohn\u2019s disease in a population-based cohort.","volume":"139","author":"Thia","year":"2010","journal-title":"Gastroenterology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn\u2019s disease.","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease.","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell."},{"key":"B8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications.","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nri3661","article-title":"Cytokines in inflammatory bowel disease.","volume":"14","author":"Neurath","year":"2014","journal-title":"Nat Rev Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.imlet.2020.06.005","article-title":"Ferroptosis mediated DSS-induced ulcerative colitis associated with Nrf2\/HO-1 signaling pathway.","volume":"225","author":"Chen","year":"2020","journal-title":"Immunol Lett."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1038\/s41418-019-0299-4","article-title":"Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia\/reperfusion.","volume":"26","author":"Li","year":"2019","journal-title":"Cell Death Differ."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01371","article-title":"RSL3 drives ferroptosis through GPX4 inactivation and ROS production in colorectal cancer.","volume":"9","author":"Sui","year":"2018","journal-title":"Front Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1097\/01.mib.0000174374.83601.86","article-title":"Low-dose oral ferrous fumarate aggravated intestinal inflammation in rats with DSS-induced colitis.","volume":"11","author":"Erichsen","year":"2005","journal-title":"Inflamm Bowel Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00384-005-0011-7","article-title":"Exacerbation of dextran sulfate sodium-induced colitis by dietary iron supplementation: role of NF-kappaB.","volume":"21","author":"Carrier","year":"2006","journal-title":"Int J Colorectal Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"6540","DOI":"10.3748\/wjg.v19.i39.6540","article-title":"Concepts of oxidative stress and antioxidant defense in Crohn\u2019s disease.","volume":"19","author":"Alzoghaibi","year":"2013","journal-title":"World J Gastroenterol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease.","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41590-021-00996-0","article-title":"Selenium-GPX4 axis protects follicular helper T cells from ferroptosis.","volume":"22","author":"Yao","year":"2021","journal-title":"Nat Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1053\/j.gastro.2022.01.004","article-title":"PUFA-Induced metabolic enteritis as a fuel for Crohn\u2019s disease.","volume":"162","author":"Schw\u00e4rzler","year":"2022","journal-title":"Gastroenterology."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15646-6","article-title":"Dietary lipids fuel GPX4-restricted enteritis resembling Crohn\u2019s disease.","volume":"11","author":"Mayr","year":"2020","journal-title":"Nat Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1136\/gut.42.4.485","article-title":"Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease.","volume":"42","author":"Sido","year":"1998","journal-title":"Gut."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-022-00652-1","article-title":"Therapeutic material basis and underling mechanisms of Shaoyao Decoction-exerted alleviation effects of colitis based on GPX4-regulated ferroptosis in epithelial cells.","volume":"17","author":"Li","year":"2022","journal-title":"Chin Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-981-13-9589-5_2","article-title":"Cellular iron metabolism and regulation.","volume":"1173","author":"Gao","year":"2019","journal-title":"Adv Exp Med Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nrgastro.2010.151","article-title":"Diagnosis and management of iron deficiency anemia in patients with IBD.","volume":"7","author":"Stein","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B24","first-page":"104","article-title":"Management of iron deficiency anemia in inflammatory bowel disease \u2013 a practical approach.","volume":"26","author":"Stein","year":"2013","journal-title":"Ann Gastroenterol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.20524\/aog.2016.0083","article-title":"Diagnosis and treatment of anemia in patients with inflammatory bowel disease.","volume":"30","author":"M\u00fccke","year":"2017","journal-title":"Ann Gastroenterol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/1061186X.2021.1971237","article-title":"Targetting ferroptosis for blood cell-related diseases.","volume":"30","author":"Chen","year":"2022","journal-title":"J Drug Target."},{"key":"B27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.crohns.2011.09.010","article-title":"Iron replacement therapy in inflammatory bowel isease patients with iron deficiency anemia: a systematic review and meta-analysis.","volume":"6","author":"Lee","year":"2012","journal-title":"J Crohns Colitis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1182\/blood-2005-03-1185","article-title":"Identification of the receptor scavenging hemopexin-heme complexes.","volume":"106","author":"Hvidberg","year":"2005","journal-title":"Blood."},{"key":"B29","doi-asserted-by":"publisher","first-page":"C1780","DOI":"10.1152\/ajpcell.00080.2012","article-title":"Heme carrier protein 1 transports heme and is involved in heme-Fe metabolism.","volume":"302","author":"Le Blanc","year":"2012","journal-title":"Am J Physiol Cell Physiol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01956","article-title":"Heme Oxygenase-1 as a Modulator of Intestinal Inflammation Development and Progression.","volume":"9","author":"Sebasti\u00e1n","year":"2018","journal-title":"Front Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1440-1827.2009.02490.x","article-title":"Rectal administration of tranilast ameliorated acute colitis in mice through increased expression of heme oxygenase-1.","volume":"60","author":"Sun","year":"2010","journal-title":"Pathol Int."},{"key":"B32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nri.2017.90","article-title":"Type 2 immunity in tissue repair and fibrosis.","volume":"18","author":"Gieseck","year":"2018","journal-title":"Nat Rev Immunol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.154799","article-title":"Interleukin-4 and interleukin-13 as possible therapeutic targets in systemic sclerosis.","volume":"125","author":"Gasparini","year":"2020","journal-title":"Cytokine."},{"key":"B34","doi-asserted-by":"publisher","first-page":"G609","DOI":"10.1152\/ajpgi.00273.2004","article-title":"Interleukin-4- and -13-induced hypercontractility of human intestinal muscle cells-implication for motility changes in Crohn\u2019s disease.","volume":"288","author":"Akiho","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4.","volume":"156","author":"Yang","year":"2014","journal-title":"Cell."},{"key":"B36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s000110050605","article-title":"Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors.","volume":"49","author":"Katori","year":"2000","journal-title":"Inflamm Res."},{"key":"B37","first-page":"65","article-title":"Role of nitric oxide-synthase and cyclooxygenase\/lipooxygenase systems in development of experimental ulcerative colitis.","volume":"62","author":"Sklyarov","year":"2011","journal-title":"J Physiol Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.7150\/ijbs.4989","article-title":"IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6.","volume":"8","author":"Rose-John","year":"2012","journal-title":"Int J Biol Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41586-021-03484-5","article-title":"A myeloid-stromal niche and gp130 rescue in NOD2-driven Crohn\u2019s disease.","volume":"593","author":"Nayar","year":"2021","journal-title":"Nature."},{"key":"B40","doi-asserted-by":"publisher","first-page":"25S","DOI":"10.1007\/BF01538128","article-title":"Interleukin-1.","volume":"33","author":"Dinarello","year":"1988","journal-title":"Dig Dis Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1136\/gutjnl-2020-321731","article-title":"Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance.","volume":"70","author":"Aschenbrenner","year":"2021","journal-title":"Gut."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1038\/s41591-021-01520-5","article-title":"IL-1-driven stromal-neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies.","volume":"27","author":"Friedrich","year":"2021","journal-title":"Nat Med."},{"key":"B43","first-page":"109","article-title":"Nitric oxide: physiology, pathophysiology, and pharmacology.","volume":"43","author":"Moncada","year":"1991","journal-title":"Pharmacol Rev."},{"key":"B44","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0039-6060(99)70098-X","article-title":"Expression of NOS II and its role in experimental small bowel ulceration in rats.","volume":"126","author":"Chen","year":"1999","journal-title":"Surgery."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01080-8","article-title":"Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy.","volume":"14","author":"Tang","year":"2021","journal-title":"J Hematol Oncol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1084\/jem.20130066","article-title":"Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4.","volume":"210","author":"Holmgaard","year":"2013","journal-title":"J Exp Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1053\/j.gastro.2019.07.013","article-title":"Epithelial Indoleamine 2,3-Dioxygenase 1 modulates aryl hydrocarbon receptor and notch signaling to increase differentiation of secretory cells and alter mucus-associated microbiota.","volume":"157","author":"Alvarado","year":"2019","journal-title":"Gastroenterology."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD[J].","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010073","article-title":"The Many Faces of CD4+ T cells: immunological and structural characteristics.","volume":"22","author":"Chatzileontiadou","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006641","article-title":"Analysis of the human monocyte-derived macrophage transcriptome and response to lipopolysaccharide provides new insights into genetic aetiology of inflammatory bowel disease.","volume":"13","author":"Baillie","year":"2017","journal-title":"PLoS Genet."},{"key":"B51","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.autrev.2014.10.012","article-title":"Regulatory T-cells in autoimmune diseases: challenges, controversies and\u2013yet\u2013unanswered questions.","volume":"14","author":"Grant","year":"2015","journal-title":"Autoimmun Rev."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109235","article-title":"The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity.","volume":"35","author":"Xu","year":"2021","journal-title":"Cell Rep."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19294-1","article-title":"Treprostinil inhibits proliferation and extracellular matrix deposition by fibroblasts through cAMP activation.","volume":"8","author":"Lambers","year":"2018","journal-title":"Sci Rep."},{"key":"B54","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3748\/wjg.14.200","article-title":"Role of the JNK signal transduction pathway in inflammatory bowel disease.","volume":"14","author":"Roy","year":"2008","journal-title":"World J Gastroenterol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"17229","DOI":"10.1074\/jbc.RA118.003926","article-title":"c-Jun N-terminal kinase (JNK)-mediated induction of mSin1 expression and mTORC2 activation in mesenchymal cells during fibrosis.","volume":"293","author":"Walker","year":"2018","journal-title":"J Biol Chem."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1058076\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T23:58:27Z","timestamp":1673567907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1058076\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,13]]},"references-count":55,"alternative-id":["10.3389\/fmed.2022.1058076"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1058076","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,13]]},"article-number":"1058076"}}